These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 15647195)
41. Urocortin I is present in the enteric nervous system and exerts an excitatory effect via cholinergic and serotonergic pathways in the rat colon. Kimura T; Amano T; Uehara H; Ariga H; Ishida T; Torii A; Tajiri H; Matsueda K; Yamato S Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G903-10. PubMed ID: 17717045 [TBL] [Abstract][Full Text] [Related]
42. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity. Hoare SR; Sullivan SK; Fan J; Khongsaly K; Grigoriadis DE Peptides; 2005 Mar; 26(3):457-70. PubMed ID: 15652653 [TBL] [Abstract][Full Text] [Related]
43. Activation of corticotropin-releasing factor receptor-2 causes bronchorelaxation and inhibits pulmonary inflammation in mice. Moffatt JD; Lever R; Page CP FASEB J; 2006 Sep; 20(11):1877-9. PubMed ID: 16855006 [TBL] [Abstract][Full Text] [Related]
45. Urocortins and the regulation of gastrointestinal motor function and visceral pain. Martinez V; Wang L; Million M; Rivier J; Taché Y Peptides; 2004 Oct; 25(10):1733-44. PubMed ID: 15476940 [TBL] [Abstract][Full Text] [Related]
46. Increase of core temperature induced by corticotropin-releasing factor and urocortin: a comparative study. Figueiredo MJ; Fabricio AS; Machado RR; Melo MC; Soares DM; Souza GE Regul Pept; 2010 Dec; 165(2-3):191-9. PubMed ID: 20691217 [TBL] [Abstract][Full Text] [Related]
47. Involvement of CRH receptors in urocortin-induced hyperthermia. Telegdy G; Adamik A Peptides; 2008 Nov; 29(11):1937-42. PubMed ID: 18775757 [TBL] [Abstract][Full Text] [Related]
48. Peripheral corticotropin-releasing factor receptor type 2 activation increases colonic blood flow through nitric oxide pathway in rats. Akiba Y; Kaunitz JD; Million M Dig Dis Sci; 2015 Apr; 60(4):858-67. PubMed ID: 25701320 [TBL] [Abstract][Full Text] [Related]
49. Protective effect of central thyrotropin-releasing hormone analog on cerulein-induced acute pancreatitis in rats. Yoneda M; Goto M; Nakamura K; Shimada T; Hiraishi H; Terano A; Haneda M Regul Pept; 2005 Feb; 125(1-3):119-24. PubMed ID: 15582722 [TBL] [Abstract][Full Text] [Related]
50. Central thyrotropin-releasing hormone stimulates hepatic DNA synthesis in rats. Yoneda M; Tamori K; Sato Y; Yokohama S; Nakamura K; Kono T; Makino I Hepatology; 1997 Nov; 26(5):1203-8. PubMed ID: 9362363 [TBL] [Abstract][Full Text] [Related]
51. Central nervous system action of corticotropin-releasing factor to inhibit gastric emptying in rats. Taché Y; Maeda-Hagiwara M; Turkelson CM Am J Physiol; 1987 Aug; 253(2 Pt 1):G241-5. PubMed ID: 3497585 [TBL] [Abstract][Full Text] [Related]
52. Regional hemodynamic actions of selective corticotropin-releasing factor type 2 receptor ligands in conscious rats. Gardiner SM; March JE; Kemp PA; Davenport AP; Wiley KE; Bennett T J Pharmacol Exp Ther; 2005 Jan; 312(1):53-60. PubMed ID: 15328375 [TBL] [Abstract][Full Text] [Related]
53. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors. Perrin MH; Sutton SW; Cervini LA; Rivier JE; Vale WW J Pharmacol Exp Ther; 1999 Feb; 288(2):729-34. PubMed ID: 9918582 [TBL] [Abstract][Full Text] [Related]
54. Human urocortin II, a new CRF-related peptide, displays selective CRF(2)-mediated action on gastric transit in rats. Million M; Maillot C; Saunders P; Rivier J; Vale W; Taché Y Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G34-40. PubMed ID: 11751155 [TBL] [Abstract][Full Text] [Related]
55. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat. Arborelius L; Skelton KH; Thrivikraman KV; Plotsky PM; Schulz DW; Owens MJ J Pharmacol Exp Ther; 2000 Aug; 294(2):588-97. PubMed ID: 10900236 [TBL] [Abstract][Full Text] [Related]
56. The role of CRF2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia. Smagin GN; Howell LA; Ryan DH; De Souza EB; Harris RB Neuroreport; 1998 May; 9(7):1601-6. PubMed ID: 9631473 [TBL] [Abstract][Full Text] [Related]
57. Urocortin, corticotropin releasing factor-2 receptors and energy balance. Cullen MJ; Ling N; Foster AC; Pelleymounter MA Endocrinology; 2001 Mar; 142(3):992-9. PubMed ID: 11181511 [TBL] [Abstract][Full Text] [Related]
59. Central injection of astressin inhibits carbon tetrachloride-induced acute liver injury in rats. Nakade Y; Yoneda M; Yokohama S; Tamori K; Nakamura K; Watanobe H; Kono T; Makino I; Terano A Eur J Pharmacol; 2003 Jan; 460(2-3):135-8. PubMed ID: 12559373 [TBL] [Abstract][Full Text] [Related]
60. Role of corticotropin-releasing factor receptor-2 in stress-induced suppression of pulsatile luteinizing hormone secretion in the rat. Li XF; Bowe JE; Lightman SL; O'Byrne KT Endocrinology; 2005 Jan; 146(1):318-22. PubMed ID: 15388651 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]